Clinical trial
Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head…
NCT00184028 · University of Southern California, Other · Terminated
Key facts
| NCT number | NCT00184028 |
|---|---|
| Title | Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck |
| Official title | Phase II Trial of Taxotere and Oxaliplatin Combination Chemotherapy in Squamous Cell Carcinoma of the Head and Neck |
| Lead sponsor | University of Southern California, Other |
| Collaborators | Sanofi Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma of the Head and Neck |
| Intervention type | Drug |
| Interventions | Taxotere, Oxaliplatin |
| Enrollment | 12 |
| Start date | Sep 1, 2004 |
| Primary completion | Jul 1, 2009 |
| Completion | Jul 1, 2010 |
| First posted | Sep 16, 2005 |
| Last update posted | May 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: